Abstract
While developmental and behavioral interventions are the primary treatment methods for youth with ASD, psychotropic medications are often prescribed by psychiatrists, developmental-behavioral pediatricians, and sometimes primary care clinicians (PCCs) to manage co-occurring disorders and symptoms. To maximize the effectiveness of these medications, collaborations across family, medical, community, and school systems are needed. However, there are numerous barriers unique to interprofessional collaboration around psychotropic prescribing for children with ASD. As such, this chapter aims to discuss these unique barriers, outline models of interprofessional care, and describe specific interprofessional and collaborative roles between prescribers and non-prescribers to support effective psychotropic management for children with ASD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Haidar, F. A. (2008). Parental attitudes toward the prescription of psychotropic medications for their children. Journal of Family and Community Medicine, 15, 35–42.
Aman, M. G., Farmer, C. A., Hollway, J., & Arnold, L. E. (2008). Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 17, 713–738.
American Pharmacists Association and the National Association of Chain Drug Stores Foundation. (2008). Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). Journal of the American Pharmacists Association, 48, 341–353.
Brachlow, A. E., Ness, K. K., McPheeters, M. L., & Gurney, J. G. (2007). Comparison of indicators for a primary care medical home between children with autism or asthma and other special health care needs: National Survey of Children’s Health. Archives of Pediatrics and Adolescent Medicine, 161(4), 399–405.
Carbone, P., Behl, D., Azor, V., & Murphy, N. (2010). The medical home for children with autism spectrum disorders: Parent and pediatrician perspectives. Journal of Autism and Developmental Disorders, 40(3), 317–324.
Carbone, P., Murphy, N., Norlin, C., Azor, V., Sheng, X., & Young, P. (2013). Parent and pediatrician perspectives regarding the primary care of children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 43, 964–972.
DuPaul G. J., & Franklin M. K. (2019). Legal, Ethical, and Professional Issues Related to Use of Psychotropic Medications in School-Aged Populations. In J. Carlson & J. Barterian (Eds.), School psychopharmacology. Pediatric school psychology. Cham: Springer.
Frazier, T. W., Shattuck, P. T., Narendorf, S. C., Cooper, B. P., Wagner, M., & Spitznagel, E. L. (2011). Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 21(6), 571–579.
Gureasko-Moore, D., DuPaul, G. J., & Power, T. J. (2005). Stimulant treatment for ADHD: Medication monitoring practices of school psychologists. School Psychology Review, 34, 232–245.
Health Resources and Services Administration/National Center for Health Workforce Analysis; Substance Abuse and Mental Health Services Administration/Office of Policy, Planning, and Innovation. (2015). National Projections of Supply and Demand for Behavioral Health Practitioners: 2013–2025. Rockville, Maryland. Retrieved from https://www.mdedge.com/clinicalneurologynews/article/58501/health-policy/neurology-shortfall-worsen-2025
Heneghan, A., Garner, A. S., Storfer-Isser, A., Kortepeter, K., Stein, R. E., & Horwitz, S. M. (2008). Pediatricians’ role in providing mental health care for children and adolescents: Do pediatricians and child and adolescent psychiatrists agree? Journal of Developmental and Behavioral Pediatrics, 29, 262–269.
Herman, K. C., Cho, E., Marriott, B. R., & Walker, L. Y. (2018). Bridging the gap in psychiatric care for children with a school-based psychiatry program. School Mental Health, 10(2), 181–189.
Individuals with Disabilities Education Act. (2004). 20 U.S.C. § 1400.
Joint Commission of Pharmacy Practitioners. (2014). Pharmacists’ patient care process. https://jcpp.net/wp-content/uploads/2016/03/PatientCareProcess-with-supporting-organizations.pdf. Accessed 26 Jan 2020.
Katon, W., Von Korff, M., Lin, E., Walker, E., Simon, G. E., Bush, T., … & Russo, J. (1995). Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA, 273(13), 1026–1031.
Koegel, L. K., Krasno, A. M., Taras, H., Koegel, R. L., & Frea, W. (2013). Is medication information for children with autism spectrum disorder monitored and coordinated across professionals? findings from a teacher survey. School Mental Health, 5(1), 48–57.
Kogan, M. D., Strickland, B. B., Blumberg, S. J., Singh, G. K., Perrin, J. M., & van Dyck, P. C. (2008). A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005–2006. Pediatrics, 122(6), e1149–e1158.
Kozminski, M., Busby, R., McGivney, M. S., Klatt, P. M., Hackett, S. R., & Merenstein, J. H. (2011). Pharmacist integration into the medical-home: Qualitative analysis. Journal of the American Pharmacists Association, 51(2), 173–183.
Kirsch, A. C., Huebner, A. R. S., Mehta, S. Q., Howie, F. R., Weaver, A. L., Myers, S. M., ….& Katusic, S. K. (2020). Association of comorbid mood and anxiety disorders with autism spectrum disorder. JAMA Pediatrics, 174, 63–70.
Logan, S. L., Nicholas, J. S., Carpenter, L. A., King, L. B., Garrett-Mayer, E., & Charles, J. M. (2012). High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network. Annals of Epidemiology, 22(1), 1–8.
Madden, J. M., Lakoma, M. D., Lynch, F. L., Rusinak, D., Owen-Smith, A. A., Coleman, K. J., … & Croen, L. A. (2018). Psychotropic medication use among insured children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 47, 144–154.
Mazurek, M. O., Brown, R., Curran, A., & Sohl, K. (2017). ECHO autism: A new model for training primary care providers in best-practice care for children with autism. Clinical Pediatrics, 56(3), 247–256.
Meadows, T., Valleley, R., Haack, M. K., Thorson, R., & Evans, J. (2011). Physician “costs” in providing behavioral health in primary care. Clinical Pediatrics, 50, 447–455.
Myers, S. M., & Johnson, C. P. (2007). Management of children with autism spectrum disorders. Pediatrics, 120(5), 1162–1182.
Njoroge, W. F., Hostutler, C. A., Schwartz, B. S., & Mautone, J. A. (2016). Integrated behavioral health in pediatric primary care. Current Psychiatry Reports, 18(12), 106.
Plax, K., & Garwood, S. (2018). Integrating Behavioral Health into a School Based Health Center. Pediatrics, 141(1 MeetingAbstract), 187–187. https://doi.org/10.1542/peds.141.1_meetingabstract.187
Polaha, J., Dalton, W. T., & Allen, S. (2011). The prevalence of emotional and behavior problems in pediatric care serving rural children. Journal of Pediatric Psychology, 36, 652–660.
Power, T. J., DuPaul, G. J., Shapiro, E. S., & Kazak, A. E. (2003). Promoting children’s health: Integrating health, school, family, and community systems. Guilford.
Power, T. J., Michel, J., Mayne, S., Miller, J., Blum, N. J., Grundmeier, R. W., … & Fiks, A. G. (2016). Coordinating systems of care using health information technology: Development of the ADHD care assistant. Advances in School Mental Health Promotion, 9(3–4), 201–218.
Riley, A. R., Paternostro, J. K., Walker, B. L., & Wagner, D. V. (2019). The impact of behavioral health consultations on medical encounter duration in pediatric primary care: A retrospective match-controlled study. Families, Systems, & Health, 37(2), 162.
Ryan, J. B., Katsiyannis, A., Losinski, M., Reid, R., & Ellis, C. (2014). Review of state medication policies/guidelines regarding psychotropic medications in public schools. Journal of Child and Family Studies, 23(4), 704–715.https://doi.org/10.1007/s10826-013-9805-3
Sarvet, B., Gold, J., Bostic, J. Q., Masek, B. J., Prince, J. B., Jeffers-Terry, M., et al. (2010). Improving access to mental health care for children: The Massachusetts Child Psychiatry Access Project. Pediatrics, 126, 1191–1200.
Santosh, P. J., Bell, L., Fiori, F., & Singh, J. (2017). Pediatric antipsychotic use and outcomes monitoring. Journal of Child and Adolescent Psychopharmacology, 27(6), 546–554.
Scott, M. A., Hitch, B., Ray, L., & Colvin, G. (2011). Integration of pharmacists into a patient-centered medical home. Journal of the American Pharmacists Association, 51(2), 161–166.
Section 504 of the Rehabilitation Act of 1973, 34. C.F.R. Part 104.
Shahidullah, J. D., & Carlson, J. S. (2014). Survey of Nationally Certified School Psychologists’ roles and training in psychopharmacology. Psychology in the Schools, 51, 705–721.
Shahidullah, J., Hostutler, C. A., & Stancin, T. (2018a). Collaborative medication-related roles for pediatric primary care psychologists. Clinical Practice in Pediatric Psychology, 6(1), 61–72.
Shahidullah, J. D., Kettlewell, P. W., Palejwala, M. H., Forman, S. G., Billups, A., Anismatta, S. L., et al. (2018b). Behavioral health training in pediatric residency programs: a national survey of training directors. Journal of Developmental and Behavioral Pediatrics, 39(4), 292–302.
Shahidullah, J. D., Hostutler, C. A., & Forman, S. G. (2019). Ethical considerations in medication-related roles for pediatric primary care psychologists. Clinical Practice in Pediatric Psychology, 7(4), 405.
Sharma, V., Stranieri, A., Burstein, F., Warren, J., Daly, S., Patterson, L., … & Wolff, A. (2016). Group decision making in health care: A case study of multidisciplinary meetings. Journal of Decision Systems, 25(sup1), 476–485.
Shaw, S. R., Glaser, S. E., & Ouimet, T. (2011). Developing the medical liaison role in school settings. Journal of Educational and Psychological Consultation, 21, 106–117.
Sohl, K., Mazurek, M. O., & Brown, R. (2017). ECHO autism: Using technology and mentorship to bridge gaps, increase access to care, and bring best practice autism care to primary care. Clinical Pediatrics, 56, 509–511.
Smyer, M. A., Balster, R. L., Egli, D., Johnson, D. L., Kilbey, M. M., Leith, N. J., et al. (1993). Summary of the report of the ad hoc task force on psychopharmacology of the American Psychological Association. Professional Psychology: Research and Practice, 2, 394–403.
Straus, J. H., & Sarvet, B. (2014). Behavioral health care for children: The Massachusetts Child Psychiatry Access Project. Health Affairs, 33, 2153–2161.
Strunk, J. A. (2009). School nurses’ knowledge of autism spectrum disorders. The Journal of School Nursing, 25(6), 445–452.
Swiezy, N., Stuart, M., & Korzekwa, P. (2008). Bridging for success in autism: Training and collaboration across medical, educational, and community systems. Child and Adolescent Psychiatric Clinics of North America, 17(4), 907–922.
Towbin, K. E. (2003). Strategies for pharmacologic treatment of high functioning autism and Asperger syndrome. Child and Adolescent Psychiatric Clinics of North America, 12, 23–45.
Van Cleave, J., Holifield, C., Neumeyer, A. M., Perrin, J. M., Powers, E., Van, L., et al. (2018). Expanding the capacity of primary care to treat co-morbidities in children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 48(12), 4222–4230.
Wegner, S. E., Humble, C. G., Feaganes, J., & Stiles, A. D. (2008). Estimated savings from paid telephone consultations between subspecialists and primary care physicians. Pediatrics, 122, e1136–e1140.
Wongpakaran, R., Suansanae, T., Tan-khum, T., Kraivichian, C., Ongarjsakulman, R., & Suthisisang, C. (2017). Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study. Journal of Clinical Pharmacy and Therapeutics, 42(3), 329–336.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hostutler, C.A., Shahidullah, J.D., Baum, R.A., Groves, B.K. (2020). Interprofessional Roles to Support Psychotropic Medication Prescribing for ASD. In: McClain, M., Shahidullah, J., Mezher, K. (eds) Interprofessional Care Coordination for Pediatric Autism Spectrum Disorder. Springer, Cham. https://doi.org/10.1007/978-3-030-46295-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-46295-6_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-46294-9
Online ISBN: 978-3-030-46295-6
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)